- United States
- /
- Healthcare Services
- /
- NasdaqCM:JYNT
Joint (NASDAQ:JYNT) Shareholders Will Want The ROCE Trajectory To Continue
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, we've noticed some promising trends at Joint (NASDAQ:JYNT) so let's look a bit deeper.
Understanding Return On Capital Employed (ROCE)
For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for Joint, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)
0.028 = US$2.0m ÷ (US$98m - US$25m) (Based on the trailing twelve months to March 2023).
Thus, Joint has an ROCE of 2.8%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 9.5%.
View our latest analysis for Joint
Above you can see how the current ROCE for Joint compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Joint.
SWOT Analysis for Joint
- Debt is not viewed as a risk.
- Earnings declined over the past year.
- Annual revenue is forecast to grow faster than the American market.
- Trading below our estimate of fair value by more than 20%.
- Annual earnings are forecast to decline for the next 2 years.
The Trend Of ROCE
The fact that Joint is now generating some pre-tax profits from its prior investments is very encouraging. Shareholders would no doubt be pleased with this because the business was loss-making five years ago but is is now generating 2.8% on its capital. In addition to that, Joint is employing 481% more capital than previously which is expected of a company that's trying to break into profitability. This can tell us that the company has plenty of reinvestment opportunities that are able to generate higher returns.
The Key Takeaway
To the delight of most shareholders, Joint has now broken into profitability. And investors seem to expect more of this going forward, since the stock has rewarded shareholders with a 78% return over the last five years. So given the stock has proven it has promising trends, it's worth researching the company further to see if these trends are likely to persist.
One more thing to note, we've identified 1 warning sign with Joint and understanding it should be part of your investment process.
While Joint isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NasdaqCM:JYNT
Flawless balance sheet with moderate growth potential.